Related Experiment Video
Updated: Jun 3, 2025

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
Chain Transfer Kinetics of Rhodixan® A1 RAFT/MADIX Agent
Mathias Destarac1, Aymeric Guinaudeau1,2, Stéphane Mazières1
1Laboratoire SOFTMAT, CNRS UMR 5623, University of Toulouse, University Toulouse III-Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex 9, France.
Rhodixan® A1, a RAFT/MADIX agent, enables industrial-scale production of block copolymer additives. It achieves predetermined molecular weights across various monomers, with transfer coefficients varying by monomer type.
Area of Science:
- Polymer Chemistry
- Materials Science
Background:
- Industrial-scale production of block copolymer additives is crucial for aqueous formulations.
- Reversible-Deactivation Radical Polymerization (RDRP) techniques, including RAFT/MADIX, offer control over polymer architecture.
- Rhodixan® A1 (O-ethyl S-(1-methoxycarbonylethyl)dithiocarbonate) is a key RAFT/MADIX agent.
Purpose of the Study:
- To evaluate the effectiveness of Rhodixan® A1 in producing block copolymer additives.
- To determine chain transfer coefficients for Rhodixan® A1 with various monomer classes.
- To assess the control over polymer molecular weight and dispersity.
Main Methods:
- Utilized 25 different styrenic, acrylate, and acrylamide monomers.
- Experimentally determined chain transfer coefficients (Ctr) and interchain transfer coefficients (Ctr,PnXA1).
- Analyzed polymer molecular weight and dispersity at high monomer conversion.
Main Results:
- Chain transfer coefficients to Rhodixan® A1 were low, ranging from 0.6 to 3.8.
- Transfer coefficients followed the order: styrenics < acrylates < acrylamides.
- Polymers with predetermined molecular weights were obtained with dispersities inversely proportional to Ctr,PnXA1.
Conclusions:
- Rhodixan® A1 facilitates the industrial-scale synthesis of block copolymers with controlled molecular weights.
- The RAFT/MADIX technique using Rhodixan® A1 is versatile for creating complex copolymers from monomers with differing reactivities.
- This agent is effective for both conjugated and unconjugated monomers, expanding its applicability.
Related Concept Videos
Radical Chain-Growth Polymerization: Overview
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

